Discovery of oxysterol-derived pharmacological chaperones for NPC1: implication for the existence of second...

Area of Science:

• Biochemistry
• Cell Biology
• Genetics

Background:

• Niemann-Pick type C1 (NPC1) is crucial for cholesterol efflux from endosomes.
• Mutations in NPC1 cause Niemann-Pick disease type C, a fatal neurodegenerative disorder.
• The I1061T mutation leads to NPC1 misfolding and loss-of-function.

Purpose of the Study:

• To identify compounds that can correct the NPC1 folding defect.
• To investigate the therapeutic potential of these compounds for Niemann-Pick disease.

Main Methods:

• Screening of oxysterols and derivatives as potential pharmacological chaperones.
• Assessing the effect of compounds on I1061T NPC1 localization and maturation in cells.
• Evaluating intracellular cholesterol levels in patient-derived fibroblasts.

Main Results:

• Several oxysterols and derivatives function as pharmacological chaperones for I1061T NPC1.
• These compounds restore proper localization and maturation of the mutant NPC1 protein.
• Treatment with these compounds reduces cholesterol accumulation in patient cells.
• Oxysterol derivatives bind to a novel sterol-binding site on NPC1.

Conclusions:

• Oxysterols can serve as effective pharmacological chaperones for mutant NPC1.
• This approach shows therapeutic promise for Niemann-Pick disease type C.
• NPC1 possesses an additional sterol-binding site beyond the known N-terminal domain.